Weihua Zeng

Weihua Zeng, PhD, is a scientist and consultant at Abbott Molecular, specializing in the development of Companion Diagnostics (CDx) and In-Vitro Diagnostic (IVD) products. With over thirteen years of clinical lab research experience, they have a strong background in immunology, cellular/molecular biology, and genomics, particularly in relation to autoimmune diseases and hematologic malignancies. Weihua has authored 26 peer-reviewed articles and 10 abstracts, demonstrating their expertise in small molecular and biologics drug discovery. They are fluent in English, Japanese, and Chinese, and possess robust technical skills across various immunoassays and molecular biology techniques. Previously, Weihua held positions at institutions such as the Astellas Research Institute of America, the University of New Mexico, and the National Institutes of Health.